Pathstone Family Office’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.81M | Buy |
11,001
+3,656
| +50% | +$1.6M | 0.04% | 275 |
|
|
2023
Q2 | $3.68M | Buy |
7,345
+913
| +14% | +$457K | 0.05% | 210 |
|
|
2023
Q1 | $3.25M | Sell |
6,432
-12,092
| -65% | -$6.11M | 0.05% | 207 |
|
|
2022
Q4 | $6.76M | Buy |
18,524
+2,833
| +18% | +$1.03M | 0.06% | 232 |
|
|
2022
Q3 | $5.11M | Buy |
15,691
+11,794
| +303% | +$3.84M | 0.05% | 230 |
|
|
2022
Q2 | $1.37M | Buy |
3,897
+1,420
| +57% | +$498K | 0.03% | 278 |
|
|
2022
Q1 | $1.36M | Sell |
2,477
-215
| -8% | -$118K | 0.03% | 253 |
|
|
2021
Q4 | $1.77M | Buy |
2,692
+202
| +8% | +$133K | 0.04% | 212 |
|
|
2021
Q3 | $1.55M | Sell |
2,490
-6
| -0.2% | -$3.73K | 0.05% | 204 |
|
|
2021
Q2 | $1.58M | Sell |
2,496
-51
| -2% | -$32.2K | 0.05% | 185 |
|
|
2021
Q1 | $1.25M | Buy |
2,547
+2,453
| +2,610% | +$1.2M | 0.04% | 180 |
|
|
2020
Q4 | $47K | Buy |
+94
| New | +$47K | ﹤0.01% | 520 |
|
|
2019
Q2 | – | Sell |
-8
| Closed | -$2K | – | 754 |
|
|
2019
Q1 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 771 |
|